AuroMedics Piperacillin-Tazobactam Injection Recall: Particulate Matter Hazard
AuroMedics Pharma recalls Piperac:illin-Tazobactam injection vials with glass/silicone particles that could cause serious injury. Affected vials have specific NDC and lot numbers.
Stop using this now
Presence of Particulate Matter: identified as glass and silicone material
Contact the company
What happened, in plain English
AuroMedics Pharma recalled certain Piperacillin-Tazobactam injection vials due to glass and silicone particles that could cause serious injury. This recall affects vials with specific NDC and lot numbers. Read more at govinfonow.com/recall/40387-auromedics-piperacillin-tazobactam-injection-recall-particulate-matter-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/40387-auromedics-piperacillin-tazobactam-injection-recall-particulate-matter-hazard · Updated October 6, 2026 · FDA enforcement record: FDA #D-1030-2018
Cite this page
“AuroMedics Piperacillin-Tazobactam Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/40387-auromedics-piperacillin-tazobactam-injection-recall-particulate-matter-hazard. Based on FDA recall #D-1030-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1030-2018%22&limit=1).
Why it’s dangerous
The vials contain glass and silicone particles that could cause serious injury when injected. These particles may lead to tissue damage, infection, or other complications during medical procedures.
Who’s affected
Healthcare professionals using these injections for medical treatment. Patients receiving these medications are at risk if they use the recalled vials.
How to tell if you have this one
Check for vials labeled 'Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only'. Look for NDC 55150-120-30 and lot numbers PP0317059-A (expiring February 2019) or PP0317012-A (expiring August 2019).
- Brand
AuroMedics- Category
Drug
What to do — step by step
Stop Using Now
Immediately discard any vials with the NDC 55150-120-30 and lot numbers PP0317059-A or PP0317012-A.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 6.3 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class I
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1030-2018 (July 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1030-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.